Vietnam to use Evusheld for COVID-19 prevention beginning Saturday
(VOVWORLD) - The Tam Anh hospitals in Hanoi and HCM city will start administering AstraZeneca’s Evusheld antibody beginning Saturday, with priority given to people who are most at risk for viral infections.
 (Photo: baotintuc.vn) |
Evusheld, a long-acting monoclonal antibody, serves as a prevention therapy for high-risk people that protects them from COVID-19 infection before they are actually exposed to the virus.
Tran Quang Binh, chief medical director at Tam Anh General Hospital in HCMC told VnExpress that Evusheld can protect those who cannot get the COVID-19 vaccine or have not generated sufficient antibodies after being fully vaccinated.